24×7 Emergency Care

1-8-31/1, Minister Road, Secunderabad, Telangana 500003

EMERGENCY:Sudden step-down in cognition or new neurological symptom — this may indicate a new stroke —call040-46324365immediately — 24 hours, 7 days— 24/7

COGNITIVE & NEUROPSYCHOLOGICAL DISORDERS

Vascular Dementia — Specialist Diagnosis and Management in Hyderabad at KIMS

Q: My father had a stroke 2 years ago and has been getting progressively worse cognitively since then. He seems to have sudden episodes where he drops a level and never recovers to his previous level. Is this vascular dementia?

Yes — the pattern you describe (cognitive decline that occurs in steps, each step coinciding with a vascular event, with plateaus of relative stability between steps) is the classic picture of multi-infarct vascular dementia. Each step down represents another stroke — sometimes a clinically obvious stroke, sometimes a silent lacunar infarct detected only on MRI. The trajectory of VaD differs fundamentally from Alzheimer's disease (which declines gradually and smoothly). At KIMS, the assessment will: confirm the vascular dementia diagnosis · Identify the specific mechanism of the ongoing strokes (cardioembolism from AF? Large vessel atherosclerosis? Small vessel hypertensive disease?) · Optimise the treatment to prevent further steps (antiplatelet or anticoagulation, BP control, statin) · Provide cognitive rehabilitation to maximise function at the current level. Call 040-44885000.

Q: My mother has been diagnosed with vascular dementia from small vessel disease. Her brain scan shows a lot of white matter changes. She has high blood pressure and diabetes. If we control these now, will the dementia improve?

Controlling blood pressure and diabetes now will not reverse the white matter damage that has already occurred, but it will significantly slow further progression. White matter hyperintensities from SVD reflect areas of demyelination and axonal loss from chronic ischaemia of the deep white matter perforating arteries — and this damage is permanent. However, ongoing hypertension and poorly controlled diabetes continue to injure new areas of white matter and to cause new lacunar infarcts. Every new lesion represents another reduction in cognitive reserve. By controlling BP to below 130/80 mmHg and HbA1c to a safe target, you can stabilise the white matter burden and prevent further cognitive steps. This is the most powerful intervention available for SVD-related VaD. Physical exercise improves cerebral blood flow and white matter integrity independently of BP. Call 040-44885000.

Q: How do you tell the difference between vascular dementia and Alzheimer's disease? My mother has been given both diagnoses by different doctors.

The distinction — and the reason different doctors give different diagnoses — is that many elderly patients have features of both. Alzheimer's disease (AD): gradual, smooth decline from the very beginning · Memory loss is the first and most prominent symptom · The person forgets events entirely and cannot benefit from prompts · No focal neurological signs · MRI: hippocampal atrophy · No (or incidental) white matter changes. Vascular dementia (VaD): stepwise or fluctuating decline · Executive dysfunction and slowed thinking early, memory less impaired initially · Clear vascular risk factors or stroke history · Focal neurological signs (mild weakness, gait disturbance) · MRI: significant white matter hyperintensity, lacunae, infarcts. Mixed dementia: features of both — the most common reality in the elderly. At KIMS, detailed neuropsychological testing combined with MRI and (where indicated) CSF or amyloid PET biomarkers provides the most accurate distinction, which matters for treatment (the vascular component responds to risk factor control; the AD component to cholinesterase inhibitors). Call 040-44885000.

Q: My 60-year-old husband has been told he has significant white matter changes on his MRI but no dementia yet. He has been told this is a risk factor. What should he do now?

White matter hyperintensities (WMH) on MRI reflect underlying cerebral small vessel disease — damage to the small perforating arteries supplying the deep white matter, almost always from hypertension and/or diabetes. Significant WMH without dementia represents vascular cognitive impairment without dementia (VCIND), which is the vascular equivalent of MCI — elevated risk of progression to vascular dementia if risk factors are uncontrolled. The intervention at this stage, when the brain has been warned but not disabled, is the most impactful: blood pressure to <130/80 mmHg (this is the single most important intervention) · HbA1c <7% · Statin for LDL <70 mg/dL · Smoking cessation immediately · 150 minutes/week aerobic exercise · Alcohol moderation · Antiplatelet therapy if prior cerebrovascular events. Annual MRI to monitor WMH burden progression. Neuropsychological assessment at KIMS now establishes a baseline against which future change will be measured. Call 040-44885000.

Vascular dementia (VaD) is the second most common form of dementia globally and in India, accounting for approximately 15–20% of all dementia cases. It is caused by cerebrovascular disease — damage to the brain from ischaemia (reduced blood supply) or haemorrhage — that impairs cognitive function to the degree that daily activities are significantly affected. Unlike Alzheimer's disease, which is caused by intrinsic neurodegeneration, vascular dementia is caused by external vascular injury to the brain: it is, in principle, preventable and partially modifiable by controlling the underlying vascular risk factors.

View Our Specialists

VaD is the second most common dementia (15-20% of all cases globally and in India), caused by cerebrovascular disease that impairs cognition to the point of significant ADL impairment. Unlike Alzheimer's (intrinsic neurodegeneration), VaD is caused by external vascular injury to the brain and is, in principle, preventable and partially modifiable. Three subtypes: (1) Multi-infarct dementia (MID): multiple large cortical/subcortical infarcts causing stepwise cognitive decline — each clinical or silent stroke produces a step-down from which the patient never fully recovers; (2) Small vessel disease (SVD) dementia: diffuse white matter damage from lipohyalinosis (fibrinoid degeneration of small perforating arteries) from chronic hypertension and diabetes; gradual, frontal-subcortical decline (executive dysfunction > memory); (3) Strategic single infarct: one small infarct in a critical location (thalamus, caudate, angular gyrus) causing disproportionate cognitive impairment. Clinical distinction from Alzheimer's: VaD = stepwise decline + executive > memory + clear vascular risk factors/stroke history + MRI white matter changes + focal neurological signs; AD = gradual + memory > executive + no focal signs + MRI hippocampal atrophy. NINDS-AIREN criteria: dementia + cerebrovascular disease + temporal relationship. Mixed dementia (VaD + AD) is probably the most common form overall.

SVD lipohyalinosis — the mechanism of white matter damage: Cerebral small vessel disease (SVD) results from lipohyalinosis: fibrinoid degeneration of the wall of the small perforating arteries (lenticulostriate, thalamoperforator, pontine perforators) that supply the deep white matter and basal ganglia. Chronic hypertension and diabetes drive this degenerative process. The result: widespread ischaemic damage to the cerebral white matter, disrupting the long-range connections between cortical regions and subcortical circuits that support executive function, processing speed, and attention. MRI: periventricular and subcortical FLAIR hyperintensities (Fazekas scale 1-3) + lacunar infarcts.
Strategic infarct sites — maximum cognitive impact from small lesions: Thalamus: bilateral paramedian thalamic infarction (from top-of-basilar artery embolism affecting the artery of Percheron) — produces a dramatic amnestic syndrome with hypersomnia, disproportionate to the small bilateral infarcts. Caudate nucleus: executive dysfunction + personality change + apathy. Angular gyrus (left parietal): Gerstmann syndrome = acalculia + agraphia + finger agnosia + right-left disorientation. This specific syndrome from a small angular gyrus infarct is one of the most precise lesion-to-symptom mappings in clinical neurology.
Stepwise vs gradual — the clinical distinction from Alzheimer's: VaD: stepwise deterioration punctuated by vascular events (sometimes clinically obvious strokes, sometimes silent lacunar infarcts). Cognitive function drops at each event and never fully recovers to the pre-event baseline. Periods of relative stability between steps. Executive dysfunction (planning, organising, initiating) and processing speed reduction are early and prominent; episodic memory, while ultimately affected, is less impaired than in AD. AD: smooth, gradual, continuous decline. Episodic memory loss (forgetting events entirely, even with cues — the memory was never stored) is the earliest and most prominent feature. No focal neurological signs.
Mixed dementia — the most common clinical reality: In clinical practice, most elderly patients with dementia have features of both Alzheimer's disease (amyloid and tau pathology) and significant cerebrovascular disease (white matter changes, lacunae). This mixed dementia is probably the most common form of dementia in the elderly overall. The clinical implication: managing the vascular component (blood pressure, diabetes, antiplatelet therapy) is worthwhile even in patients primarily diagnosed with Alzheimer's, because cerebrovascular disease accelerates the clinical expression of Alzheimer's pathology. Neither diagnosis alone tells the complete story.
NINDS-AIREN criteria: Three elements required: (1) DEMENTIA: cognitive decline impairing daily activities. (2) CEREBROVASCULAR DISEASE ON IMAGING: white matter lesions, lacunae, or cortical infarcts on MRI consistent with the pattern of cognitive impairment. (3) TEMPORAL RELATIONSHIP: cognitive decline began within 3 months of a documented stroke event, OR shows abrupt onset, OR shows stepwise deterioration. When all three are present, the diagnosis of probable vascular dementia is made.
BP control is the primary intervention — not medication: No drug reverses the white matter damage that has already occurred. But aggressive blood pressure control prevents further white matter injury and new lacunar infarcts. Target: <130/80 mmHg (ACE inhibitors/ARBs preferred for additional cerebrovascular protective effects). Every new lacunar infarct and every new area of white matter damage represents another cognitive step-down. Preventing the next event is the most powerful VaD treatment available. Secondary prevention: antiplatelet therapy (aspirin or clopidogrel) for non-cardioembolic VaD; DOAC anticoagulation for atrial fibrillation; high-intensity statin.
VCIND — vascular cognitive impairment without dementia: Significant white matter changes on MRI without dementia = vascular cognitive impairment without dementia (VCIND) — the vascular equivalent of MCI. This is the window for the most impactful intervention: preventing progression from VCIND to VaD. Annual neuropsychological monitoring tracks the trajectory. Aerobic exercise independently improves cerebral blood flow and white matter integrity.

Fact	Details
Three subtypes	Multi-infarct dementia: stepwise + large vessel/embolic · SVD dementia: gradual + frontal-subcortical + lipohyalinosis from HTN/DM · Strategic infarct: small infarct, disproportionate impact (thalamus, caudate, angular gyrus)
Gerstmann syndrome	Angular gyrus infarct · Acalculia + agraphia + finger agnosia + right-left disorientation · Classic strategic infarct syndrome
VaD vs AD	VaD: stepwise + executive > memory + vascular risk factors + MRI white matter + focal signs · AD: gradual + memory > executive + no focal signs + MRI hippocampal atrophy · Mixed dementia: most common reality in elderly
NINDS-AIREN criteria	Dementia + cerebrovascular disease on imaging + temporal relationship between stroke and cognitive decline · All three required for probable VaD
Primary treatment	BP <130/80 mmHg (most important single intervention) · HbA1c 7-8% · Statin · DOAC for AF · Antiplatelet for non-cardioembolic
India context	Younger stroke onset · High HTN + diabetes prevalence · Tobacco · VaD is largely preventable with early risk factor management
Cholinesterase inhibitors	Modest evidence for VaD (positive trials in pure VaD) · Used when significant cognitive impairment present · Particularly useful in mixed VaD-AD

About This Condition

Vascular Dementia at a Glance

The essential facts that shape how vascular dementia is recognised and managed at KIMS

Prevalence

Second most common dementia · 15–20% of dementia cases globally and in India · Mixed dementia (VaD + Alzheimer's) may be most common overall.

Three main subtypes

Multi-infarct dementia: multiple large cortical infarcts · Small vessel disease (SVD): diffuse white matter damage from lipohyalinosis of small perforating arteries · Strategic single infarct: one carefully placed infarct (thalamus, caudate, angular gyrus) causing disproportionate cognitive impairment.

Cognitive profile

Frontal-subcortical: executive dysfunction + processing speed reduction + attention deficit · Memory less prominently affected than in Alzheimer's · Stepwise decline (not gradual) in multi-infarct subtype.

Classic features vs Alzheimer's

VaD: stepwise decline · Clear stroke history or vascular risk factors · MRI: white matter lesions + lacunae · Executive dysfunction > memory loss · Focal neurological signs · AD: gradual progressive decline · Memory loss earliest and most prominent · No focal signs.

MRI signature

Periventricular and subcortical white matter hyperintensities (FLAIR) · Lacunar infarcts · Microbleeds (SWI) · Cortical infarcts (multi-infarct subtype) · Strategic infarct in thalamus/caudate/angular gyrus.

Risk factors

Hypertension (most important) · Diabetes · Dyslipidaemia · Atrial fibrillation · Smoking · Obesity · Carotid artery disease.

Treatment

Aggressive vascular risk factor control · Antiplatelet therapy (aspirin/clopidogrel) for non-cardioembolic strokes · Anticoagulation for AF · Statin · Cholinesterase inhibitors (modest evidence) · Cognitive and physical rehabilitation.

India note

Younger age of stroke onset in India · High hypertension + diabetes prevalence · Tobacco and alcohol use · VaD preventable if risk factors identified early.

About This Condition

Vascular Dementia — Cerebrovascular Injury and Cognitive Decline

In India, the burden of vascular dementia is particularly high because the vascular risk factor profile of the Indian population — high rates of hypertension, diabetes, dyslipidaemia, and tobacco use, combined with high rates of stroke in younger people — creates fertile ground for the cerebrovascular disease that drives vascular cognitive impairment. The KIMS neurology and cognitive disorders clinic provides the diagnostic evaluation, risk factor optimisation, and cognitive rehabilitation that are the foundation of vascular dementia management.

Cognitive Clinic / Consultation

Speak directly with the KIMS vascular dementia and vascular risk team — all coordinated under one roof for MRI, neuropsychological testing, vascular risk optimisation, and cognitive rehabilitation.

040-44885000Cognitive disorders consultation line

The Three Vascular Mechanisms Behind Cognitive Decline

Three Subtypes of Vascular Dementia

Three foundational vascular dementia syndromes that shape clinical recognition and treatment at KIMS

Multi-infarct dementia — the classic stepwise picture

Multi-infarct dementia (MID) results from multiple large cortical or subcortical infarcts that accumulate over time, each one producing a step-down in cognitive function. The clinical signature is stepwise deterioration — periods of stable function punctuated by sudden cognitive declines that coincide with individual stroke events. Each stroke episode (which may or may not have been clinically obvious at the time) removes further neural tissue, and the patient never fully recovers to their pre-stroke cognitive baseline. MRI shows multiple cortical and subcortical infarcts in multiple vascular territories. This pattern is strongly associated with large artery disease, embolism (particularly from atrial fibrillation), and hypertensive large vessel disease.

Small vessel disease dementia — the diffuse subcortical picture

Cerebral small vessel disease (SVD) is the most common cause of vascular cognitive impairment in India. It results from lipohyalinosis (fibrinoid degeneration of the wall of small perforating arteries supplying the white matter and basal ganglia), driven by chronic hypertension and diabetes. The result is widespread, diffuse damage to the cerebral white matter — disrupting the long-range connections between cortical regions and the subcortical circuits that support executive function, processing speed, and attention. The clinical picture: a gradual, progressive decline (less stepwise than MID) dominated by frontal-subcortical features — slowed thinking, poor planning and organisation, attention deficit, apathy, and gait disorder. MRI shows extensive periventricular and subcortical white matter hyperintensity on FLAIR sequences (the Fazekas score grades severity) and multiple lacunar infarcts.

Strategic single infarct dementia — the disproportionate impact of location

A single, small infarct in a strategically critical location can produce a cognitive impairment that appears disproportionate to the lesion size. The most important strategic infarct sites are: the thalamus (particularly the mediodorsal and anterior nuclei — bilateral paramedian thalamic infarction from a top-of-basilar embolus causes a dramatic amnestic syndrome and drowsiness) · the caudate nucleus (executive dysfunction, personality change) · the angular gyrus of the left parietal lobe (Gerstmann syndrome: acalculia, agraphia, finger agnosia, right-left disorientation) · the posterior limb of the internal capsule. These strategic infarcts can mimic Alzheimer's dementia clinically but have a specific MRI correlate and a different management approach.

Treatment

Distinguishing Vascular Dementia from Alzheimer's Disease

The clinical and pathological distinctions that differentiate vascular dementia from Alzheimer's disease at KIMS

The cognitive profile difference — subcortical vs cortical

Alzheimer's disease produces a predominantly cortical dementia: episodic memory loss is the earliest and most prominent feature (the person cannot remember recent events even after a delay, cannot benefit from cues — the memory is not just retrieval-impaired, it was never properly stored). Vascular dementia produces a predominantly subcortical dementia: executive function (planning, organising, initiating) and processing speed are impaired early while episodic memory, although ultimately affected, is less prominent in the early stages. The VaD patient may remember recent events but cannot organise their day, manage their finances, or sustain attention on a complex task. This distinction guides the clinical diagnosis in the majority of cases even before imaging.

Mixed dementia — the most common reality

In clinical practice, the majority of elderly patients with dementia have a mixed picture: Alzheimer's disease pathology (amyloid and tau) coexisting with significant cerebrovascular disease. This mixed dementia may be the most common form of dementia overall. The clinical implication: managing the vascular component (risk factor control, antiplatelet therapy) is worthwhile even in patients with a primary Alzheimer's diagnosis, because vascular disease accelerates the expression of Alzheimer's pathology.

Our Diagnostic Process

Diagnosis at KIMS

Vascular dementia is diagnosed at KIMS through a structured four-stage workflow that begins with MRI-based confirmation of cerebrovascular disease and adds CSF or amyloid PET biomarkers when mixed dementia with Alzheimer's pathology is suspected :

MRI brain — the essential imaging tool

MRI FLAIR: white matter hyperintensities graded by Fazekas scale (1 = mild, 2 = moderate, 3 = severe) · DWI: acute lacunar infarcts · T1: cortical infarct volume and hippocampal atrophy · SWI: microbleeds (cerebral amyloid angiopathy vs hypertensive SVD) · MRA/CTA for large vessel disease assessment. The NINDS-AIREN criteria for vascular dementia diagnosis require: (1) dementia, (2) cerebrovascular disease on imaging, and (3) a temporal relationship between the stroke event and cognitive decline.

Neuropsychological testing — frontal-subcortical profile

Executive function tests: Trail Making Test B, Frontal Assessment Battery, Verbal Fluency (FAS) · Processing speed: Symbol Digit Modalities Test · Attention: Digit Span, Stroop test · Memory: Hopkins Verbal Learning Test (to distinguish better preserved VaD memory from severely impaired AD memory). All tests in Telugu or Hindi as appropriate.

Cardiovascular investigation

12-lead ECG (for AF) · 24–48 hour Holter monitor (for paroxysmal AF) · Echocardiogram (cardiac sources of embolism) · Carotid Doppler ultrasound (significant stenosis) · Fasting lipids, glucose, HbA1c · Blood pressure 24-hour ABPM (ambulatory monitoring).

CSF biomarkers and PET — for mixed dementia distinction

When Alzheimer's pathology is suspected alongside vascular disease: CSF Aβ42, total tau, and phospho-tau · Amyloid PET if available · FDG-PET (Alzheimer's: posterior parietal-temporal hypometabolism vs VaD: patchy frontal-subcortical hypometabolism).

Management at KIMS

The KIMS vascular dementia programme is built around three integrated care areas

Three Integrated Care Areas

Vascular Risk Control, Pharmacotherapy, and Cognitive Rehabilitation

Vascular Risk Factor Control — The Primary Intervention: The overarching principle: vascular dementia is, in principle, preventable and partially modifiable by controlling the underlying vascular risk factors. Every stroke and every new lacunar infarct represents another step down the cognitive staircase, and the most powerful intervention is preventing the next event.

Hypertension: Target <130/80 mmHg · ACE inhibitors/ARBs preferred (additional cerebrovascular protective effect) · Avoid excessive lowering in established SVD (J-curve risk).

Diabetes: HbA1c target 7–8% in elderly with dementia (avoiding hypoglycaemia) · Metformin + GLP-1 agonists preferred (additional cardiovascular benefit).

Dyslipidaemia: High-intensity statin · LDL target <70 mg/dL for established cerebrovascular disease.

Atrial fibrillation: Anticoagulation (DOAC preferred over warfarin) · Rate control · Rhythm control in eligible patients.

Antiplatelet therapy: Aspirin 75–100 mg daily or clopidogrel 75 mg for non-cardioembolic cerebrovascular disease.

Cognitive Symptoms — Pharmacotherapy: Cholinesterase inhibitors (donepezil, rivastigmine, galantamine): have modest evidence for VaD (positive trials in pure VaD) · Used at KIMS when there is significant cognitive and functional impairment · May be particularly useful in mixed VaD-AD. Memantine: evidence for moderate-severe VaD · NMDA antagonist reducing excitotoxic neuronal damage. Nimodipine: some evidence in subcortical VaD.

Non-Pharmacological — Cognitive Rehabilitation: Cognitive rehabilitation: structured programme targeting specific affected domains · Memory aids (diaries, electronic reminders) · Executive function strategies (checklists, routines) · Occupational therapy for ADL safety. Physical activity: regular aerobic exercise slows progression of SVD · Gait training (gait disorder is common in SVD).

Related Conditions

Vascular dementia belongs to the family of cognitive and neuropsychological disorders evaluated and managed at KIMS Neuroscience. Explore related conditions

Mild Cognitive Impairment Amnesia Aphasia

FAQs

Frequently Asked Questions

Yes — the pattern you describe (cognitive decline that occurs in steps, each step coinciding with a vascular event, with plateaus of relative stability between steps) is the classic picture of multi-infarct vascular dementia. Each step down represents another stroke — sometimes a clinically obvious stroke, sometimes a silent lacunar infarct detected only on MRI. The trajectory of VaD differs fundamentally from Alzheimer's disease (which declines gradually and smoothly). At KIMS, the assessment will: confirm the vascular dementia diagnosis · Identify the specific mechanism of the ongoing strokes (cardioembolism from AF? Large vessel atherosclerosis? Small vessel hypertensive disease?) · Optimise the treatment to prevent further steps (antiplatelet or anticoagulation, BP control, statin) · Provide cognitive rehabilitation to maximise function at the current level. Call 040-44885000.

Controlling blood pressure and diabetes now will not reverse the white matter damage that has already occurred, but it will significantly slow further progression. White matter hyperintensities from SVD reflect areas of demyelination and axonal loss from chronic ischaemia of the deep white matter perforating arteries — and this damage is permanent. However, ongoing hypertension and poorly controlled diabetes continue to injure new areas of white matter and to cause new lacunar infarcts. Every new lesion represents another reduction in cognitive reserve. By controlling BP to below 130/80 mmHg and HbA1c to a safe target, you can stabilise the white matter burden and prevent further cognitive steps. This is the most powerful intervention available for SVD-related VaD. Physical exercise improves cerebral blood flow and white matter integrity independently of BP. Call 040-44885000.

The distinction — and the reason different doctors give different diagnoses — is that many elderly patients have features of both. Alzheimer's disease (AD): gradual, smooth decline from the very beginning · Memory loss is the first and most prominent symptom · The person forgets events entirely and cannot benefit from prompts · No focal neurological signs · MRI: hippocampal atrophy · No (or incidental) white matter changes. Vascular dementia (VaD): stepwise or fluctuating decline · Executive dysfunction and slowed thinking early, memory less impaired initially · Clear vascular risk factors or stroke history · Focal neurological signs (mild weakness, gait disturbance) · MRI: significant white matter hyperintensity, lacunae, infarcts. Mixed dementia: features of both — the most common reality in the elderly. At KIMS, detailed neuropsychological testing combined with MRI and (where indicated) CSF or amyloid PET biomarkers provides the most accurate distinction, which matters for treatment (the vascular component responds to risk factor control; the AD component to cholinesterase inhibitors). Call 040-44885000.

White matter hyperintensities (WMH) on MRI reflect underlying cerebral small vessel disease — damage to the small perforating arteries supplying the deep white matter, almost always from hypertension and/or diabetes. Significant WMH without dementia represents vascular cognitive impairment without dementia (VCIND), which is the vascular equivalent of MCI — elevated risk of progression to vascular dementia if risk factors are uncontrolled. The intervention at this stage, when the brain has been warned but not disabled, is the most impactful: blood pressure to <130/80 mmHg (this is the single most important intervention) · HbA1c <7% · Statin for LDL <70 mg/dL · Smoking cessation immediately · 150 minutes/week aerobic exercise · Alcohol moderation · Antiplatelet therapy if prior cerebrovascular events. Annual MRI to monitor WMH burden progression. Neuropsychological assessment at KIMS now establishes a baseline against which future change will be measured. Call 040-44885000.

A father who dropped cognitively the day of his stroke and never went back up. White matter changes on the scan and a family terrified of what comes next. The difference between dementia and more dementia is vascular risk factor control, started now.

At KIMS Hyderabad, neurology, neuropsychology, and the vascular risk clinic work together. Call 040-44885000.

040-44885000

International enquiries: info@kimsneurosciences.com